Insider · CIK 0001837647

Martin Michael Robert

Reports to the SEC for 1 company · VICTORIA, A1

sec.gov

Transactions

Companies

Filings

CIK

0001837647

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-02	AUPHAurinia Pharmaceuticals Inc.A Award	Chief Business Officer	AAward	+107K sh	—	—	259,162
2022-11-07	AUPHAurinia Pharmaceuticals Inc.P Purchase	Chief Business Officer	PPurchase	+30K sh	$5.16	+$155K	89,512
2022-03-02	AUPHAurinia Pharmaceuticals Inc.A Award	Chief Business Officer	AAward	+8,500 sh	—	—	64,361
2022-03-02	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−4,849 sh	$12.01	−$58.2K	59,512
2022-03-02	AUPHAurinia Pharmaceuticals Inc. · Restricted Stock UnitA Award	Chief Business Officer	AAward	+62.4K sh	—	—	62,448
2022-03-02	AUPHAurinia Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Chief Business Officer	AAward	+107K sh	—	—	106,838
2021-11-11	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+29K sh	$18.38	+$533K	95,861
2021-11-11	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−29K sh	$28.82	−$836K	66,861
2021-11-11	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−11K sh	$29.50	−$325K	55,861
2021-11-11	AUPHAurinia Pharmaceuticals Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−29K sh	—	—	27,900
2021-11-10	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−50K sh	$31.26	−$1.56M	76,861
2021-11-10	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−10K sh	$30.55	−$306K	66,861
2021-11-09	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−50K sh	$30.17	−$1.51M	126,861
2021-11-01	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+45K sh	$3.20	+$144K	221,861
2021-11-01	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−45K sh	$31.64	−$1.42M	176,861
2021-11-01	AUPHAurinia Pharmaceuticals Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−45K sh	—	—	0
2021-09-21	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+7,500 sh	$5.30	+$39.8K	184,361
2021-09-21	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+70K sh	$6.06	+$424K	254,361
2021-09-21	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$18.38	+$184K	264,361
2021-09-21	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−87.5K sh	$24.02	−$2.1M	176,861
2021-09-21	AUPHAurinia Pharmaceuticals Inc. · Option Grant (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−7,500 sh	—	—	0
2021-09-21	AUPHAurinia Pharmaceuticals Inc. · Option Grant (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−70K sh	—	—	0
2021-09-21	AUPHAurinia Pharmaceuticals Inc. · Option Grant (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	56,900
2021-09-20	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+28.5K sh	$5.30	+$151K	205,361
2021-09-20	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−12.5K sh	$21.71	−$271K	192,861
2021-09-20	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−16K sh	$21.60	−$346K	176,861
2021-09-20	AUPHAurinia Pharmaceuticals Inc. · Option Grant (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−28.5K sh	$5.30	−$151K	7,500
2021-09-14	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+44K sh	$5.30	+$233K	220,861
2021-09-14	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−14K sh	$21.73	−$304K	206,861
2021-09-14	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−30K sh	$21.80	−$654K	176,861
2021-09-14	AUPHAurinia Pharmaceuticals Inc. · Option Grant (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−44K sh	—	—	36,000
2021-09-14	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+45K sh	$5.30	+$239K	221,861
2021-09-14	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+45K sh	$3.20	+$144K	266,861
2021-09-14	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−90K sh	$21.19	−$1.91M	176,861
2021-09-14	AUPHAurinia Pharmaceuticals Inc. · Option Grant (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−45K sh	—	—	80,000
2021-09-14	AUPHAurinia Pharmaceuticals Inc. · Option Grant (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−45K sh	—	—	45,000
2021-09-13	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+25K sh	$5.30	+$133K	201,861
2021-09-13	AUPHAurinia Pharmaceuticals Inc. · Option Grant (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−25K sh	—	—	125,000
2021-09-10	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−25K sh	$19.80	−$495K	176,861
2021-09-07	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−7,500 sh	$18.10	−$136K	176,861
2021-08-26	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−22.5K sh	$17.81	−$401K	184,361
2021-08-09	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−5,000 sh	$16.01	−$80.1K	206,861
2021-07-28	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−5,000 sh	$13.86	−$69.3K	211,861
2021-06-22	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Business Officer	SSale	−5,000 sh	$13.76	−$68.8K	216,861
2021-05-11	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+20K sh	$3.02	+$60.4K	221,861
2021-05-11	AUPHAurinia Pharmaceuticals Inc. · Option Grant (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−20K sh	—	—	0

Recent filings

Accepted (ET)
Mar 64
Martin Michael Robert0001628280-23-006529
SEC(opens sec.gov)
Nov 94
Martin Michael Robert0001628280-22-029215
SEC(opens sec.gov)
Mar 44
Martin Michael Robert0001628280-22-005130
SEC(opens sec.gov)
Nov 124
Martin Michael Robert0001628280-21-023169
SEC(opens sec.gov)
Nov 34
Martin Michael Robert0001628280-21-021477
SEC(opens sec.gov)
Sep 224
Martin Michael Robert0001628280-21-019048
SEC(opens sec.gov)

Companies

Aurinia Pharmaceuticals Inc.Chief Business OfficerAUPH

Address

#1203-4464 MARKHAM STREET

VICTORIA, A1, V8Z7X8